Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Nov 07, 2020 5:25pm
296 Views
Post# 31858272

Prediction for News release and Webinar

Prediction for News release and WebinarNews Release before Webinar
 
Guaranteed, we will see a news release before the webinar with all these updates. If I am QuestCap investor relation guy, I will release some updates on Monday and then some on Wednesday. I will also use Business Wire and PRNewswire at the same time.
 
Benefit of News updates before Webinar
 
What this will do is increase shareholder base and webinar audience 20 to 50 times at these prices. QSC stock manipulation game should be solved once for all. Most of the new people coming in to buy QSC should stay for long term as progress does not stop at launching 440 testing sites. QuestCap management already saying they have contracts to launch up to 1000 sites. So, this is just starting point and people buying QSC now will happily stay until potential is reached. By then QuestCap should have lot of money in their Bank account and can add more companies to their portfolio on the way.
 
Contract with mining industry
 
I think QuestCap already signed or close to signing contracts with mining companies. If you watch last few videos from Doug Sommerville, he said quite few times, they have regularly active discussion with mining industry. We all know “Stan Bharti” is a big in mining companies, he knows lot of people and companies in mining industry. So, it should be easy for them to sign some contracts with mining industry. I think we should get update about discussion with mining industry.
 
Contracts for setting up testing sites above 440 point
 
I would like to know, other contracts, other than Simon Shopping Malls, H&S Energy, Sandor Development Company and Brookfield Properties.
 
Roughly amount of covid-19 testing done in Columbia S.A
 
I would like to know; how many testing are done per month from Columbia portfolio company or estimated revenue per month.
 
$270k revenue estimate should be corrected
 
I think they should also update $270,000 revenue per month, per cube. As those estimates were using 150 tests, per day, per site but since that is changed as QuestCap offer 3 kind of covid-19 test now Rapid Antibody, Antigen and PCR. All these prices are different, as I understand Antibody $59, Antigen $139 and PCR is $179, So average price should be higher than $59, I think at least $70-$90.
 
Buying or Selling
Everyone should be doing their own due diligence. No one should be relying on these message board. You can use information you get for free on these boards, but do you own calculations.
 
Basic Calculations for now and our reward for holding and buying QSC for last 4-5 months.
 
As of now we can say $270k USD revenue per site, per month. So, roughly about $350k Canadian per month, per site. I think until March-April these sites should be running at full capacity. We will just calculate with 60% which is $210,000 Canadian per month, per site. Then 440 sites with $210,000 revenue per month, per site is $92.4 million per month and $1.1 billion per year. When you start calculation 1000+ sites revenue and Stock price can be much higher. Yes, it did took longer than what I expectedSo, holding for few months would make perfect sense.  

<< Previous
Bullboard Posts
Next >>